https://projenx.com/
ProJenX | MAP4K ALS and Neurodegenerative Disease Treatment
Mar 30, 2023 - ProJenX's mission is to make prosetin, a scientifically validated, first-in-class MAP4 kinase inhibitor, available for ALS and other neurodegenerative diseases.
neurodegenerative diseasealstreatment